Corrigendum] miR‑1299/NOTCH3/TUG1 feedback loop contributes to the malignant proliferation of ovarian cancer
Following the publication of the above article, a concerned reader drew to the authors' attention that the data shown for the 'CAOV3/NC mimics' experiment in Fig. 2D on p. 443 appeared to be the same as that shown for the 'TUG1‑sh+miR‑1299 inhibitors' experiment in Fig. 4H on p. 444. The authors have examined their original data, and realize that the same data was inadvertently included in the two figures. Consequently, the corrected version of Fig. 2, featuring the correct data for the 'CAOV3/NC mimics' experiment in Fig. 2D, is shown opposite. The overall conclusions of this study were not affected by this error. All the authors agree to the publication of this corrigendum, and are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this; furthermore, they apologize to the readership for any inconvenience caused. [Oncology Reports 44: 438-448, 2020; DOI: 10.3892/or.2020.7623].
| Errataetall: |
ErratumFor: Oncol Rep. 2020 Aug;44(2):438-448. - PMID 32468036 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
|---|---|
| Enthalten in: |
Oncology reports - 49(2023), 5 vom: 01. Mai |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pei, Yuqing [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
CeRNA |
|---|
| Anmerkungen: |
Date Revised 13.04.2023 published: Print-Electronic ErratumFor: Oncol Rep. 2020 Aug;44(2):438-448. - PMID 32468036 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3892/or.2023.8533 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM354660233 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM354660233 | ||
| 003 | DE-627 | ||
| 005 | 20231226062708.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3892/or.2023.8533 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1182.xml |
| 035 | |a (DE-627)NLM354660233 | ||
| 035 | |a (NLM)36960874 | ||
| 035 | |a (PII)96 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pei, Yuqing |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Corrigendum] miR‑1299/NOTCH3/TUG1 feedback loop contributes to the malignant proliferation of ovarian cancer |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 13.04.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumFor: Oncol Rep. 2020 Aug;44(2):438-448. - PMID 32468036 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Following the publication of the above article, a concerned reader drew to the authors' attention that the data shown for the 'CAOV3/NC mimics' experiment in Fig. 2D on p. 443 appeared to be the same as that shown for the 'TUG1‑sh+miR‑1299 inhibitors' experiment in Fig. 4H on p. 444. The authors have examined their original data, and realize that the same data was inadvertently included in the two figures. Consequently, the corrected version of Fig. 2, featuring the correct data for the 'CAOV3/NC mimics' experiment in Fig. 2D, is shown opposite. The overall conclusions of this study were not affected by this error. All the authors agree to the publication of this corrigendum, and are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this; furthermore, they apologize to the readership for any inconvenience caused. [Oncology Reports 44: 438-448, 2020; DOI: 10.3892/or.2020.7623] | ||
| 650 | 4 | |a Published Erratum | |
| 650 | 4 | |a NOTCH3 | |
| 650 | 4 | |a TUG1 | |
| 650 | 4 | |a ceRNA | |
| 650 | 4 | |a cell proliferation | |
| 650 | 4 | |a miR‑1299 | |
| 650 | 4 | |a ovarian cancer | |
| 700 | 1 | |a Li, Kexin |e verfasserin |4 aut | |
| 700 | 1 | |a Lou, Xiaoying |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Yue |e verfasserin |4 aut | |
| 700 | 1 | |a Dong, Xin |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Wenpeng |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Ning |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Donghong |e verfasserin |4 aut | |
| 700 | 1 | |a Cui, Wei |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Oncology reports |d 1994 |g 49(2023), 5 vom: 01. Mai |w (DE-627)NLM09366334X |x 1791-2431 |7 nnns |
| 773 | 1 | 8 | |g volume:49 |g year:2023 |g number:5 |g day:01 |g month:05 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3892/or.2023.8533 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 49 |j 2023 |e 5 |b 01 |c 05 | ||